14 Dec TPS Buy Research Report- BIVI
BIVI near $12 as of 12/14/20 close Recent IPO in late September at $10 Max Entry 13, add all the way to 11.50 on near term dips Liver treatment indication that is de-risked and a potential promising Alzheimers indication added to pipeline in 2021 Target in...